
After four months and several failed bids Astellas Pharma has signed a definitive merger agreement with US biotech firm OSI …

A new takeover bid launched by Japanese pharma company Astellas for OSI Pharma has been rejected by the company’s board. …

Astellas has launched a hostile takeover bid for OSI Pharmaceuticals, going directly to stockholders with a proposal that values the US …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

